These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 9143467)

  • 1. Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer.
    Ho S; Lau WY; Leung TW; Chan M; Johnson PJ; Li AK
    Eur J Nucl Med; 1997 Mar; 24(3):293-8. PubMed ID: 9143467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours.
    Ho S; Lau WY; Leung TW; Chan M; Ngar YK; Johnson PJ; Li AK
    Eur J Nucl Med; 1996 Aug; 23(8):947-52. PubMed ID: 8753684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors.
    Leung TW; Lau WY; Ho SK; Ward SC; Chow JH; Chan MS; Metreweli C; Johnson PJ; Li AK
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):919-24. PubMed ID: 7591903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres.
    Lau WY; Ho S; Leung TW; Chan M; Ho R; Johnson PJ; Li AK
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):583-92. PubMed ID: 9486608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution.
    Salem R; Parikh P; Atassi B; Lewandowski RJ; Ryu RK; Sato KT; Gates VL; Ibrahim S; Mulcahy MF; Kulik L; Liu DM; Riaz A; Omary RA; Kennedy AS
    Am J Clin Oncol; 2008 Oct; 31(5):431-8. PubMed ID: 18838878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres.
    Dancey JE; Shepherd FA; Paul K; Sniderman KW; Houle S; Gabrys J; Hendler AL; Goin JE
    J Nucl Med; 2000 Oct; 41(10):1673-81. PubMed ID: 11037997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors.
    Sarfaraz M; Kennedy AS; Cao ZJ; Sackett GD; Yu CX; Lodge MA; Murthy R; Line BR; Van Echo DA
    Med Phys; 2003 Feb; 30(2):199-203. PubMed ID: 12607837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up.
    Andrews JC; Walker SC; Ackermann RJ; Cotton LA; Ensminger WD; Shapiro B
    J Nucl Med; 1994 Oct; 35(10):1637-44. PubMed ID: 7931662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
    Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
    J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.
    Garin E; Tselikas L; Guiu B; Chalaye J; Edeline J; de Baere T; Assenat E; Tacher V; Robert C; Terroir-Cassou-Mounat M; Mariano-Goulart D; Amaddeo G; Palard X; Hollebecque A; Kafrouni M; Regnault H; Boudjema K; Grimaldi S; Fourcade M; Kobeiter H; Vibert E; Le Sourd S; Piron L; Sommacale D; Laffont S; Campillo-Gimenez B; Rolland Y;
    Lancet Gastroenterol Hepatol; 2021 Jan; 6(1):17-29. PubMed ID: 33166497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.
    Young JY; Rhee TK; Atassi B; Gates VL; Kulik L; Mulcahy MF; Larson AC; Ryu RK; Sato KT; Lewandowski RJ; Omary RA; Salem R
    J Vasc Interv Radiol; 2007 Nov; 18(11):1375-82. PubMed ID: 18003987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung Dose Measured on Postradioembolization
    Stella M; van Rooij R; Lam MGEH; de Jong HWAM; Braat AJAT
    J Nucl Med; 2022 Jul; 63(7):1075-1080. PubMed ID: 34772794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical feasibility of fast 3-dimensional dosimetry of the liver for treatment planning of hepatocellular carcinoma with 90Y-microspheres.
    Dieudonné A; Garin E; Laffont S; Rolland Y; Lebtahi R; Leguludec D; Gardin I
    J Nucl Med; 2011 Dec; 52(12):1930-7. PubMed ID: 22068894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional personalized Monte Carlo dosimetry in 90Y resin microspheres therapy of hepatic metastases: nontumoral liver and lungs radiation protection considerations and treatment planning optimization.
    Petitguillaume A; Bernardini M; Hadid L; de Labriolle-Vaylet C; Franck D; Desbrée A
    J Nucl Med; 2014 Mar; 55(3):405-13. PubMed ID: 24504053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan.
    Chiesa C; Maccauro M; Romito R; Spreafico C; Pellizzari S; Negri A; Sposito C; Morosi C; Civelli E; Lanocita R; Camerini T; Bampo C; Bhoori S; Seregni E; Marchianò A; Mazzaferro V; Bombardieri E
    Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):168-97. PubMed ID: 21386789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Internal Radiation Therapy With Yttrium-90 Glass Microspheres: Biases and Uncertainties in Absorbed Dose Calculations Between Clinical Dosimetry Models.
    Mikell JK; Mahvash A; Siman W; Baladandayuthapani V; Mourtada F; Kappadath SC
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):888-896. PubMed ID: 27623307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Dose Response in Yttrium-90 Resin Microsphere Embolization for Neuroendocrine Liver Metastases: A Tumor-Specific Analysis with Dose Estimation Using SPECT-CT.
    Chansanti O; Jahangiri Y; Matsui Y; Adachi A; Geeratikun Y; Kaufman JA; Kolbeck KJ; Stevens JS; Farsad K
    J Vasc Interv Radiol; 2017 Nov; 28(11):1528-1535. PubMed ID: 28888827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization.
    Kao YH; Hock Tan AE; Burgmans MC; Irani FG; Khoo LS; Gong Lo RH; Tay KH; Tan BS; Hoe Chow PK; Eng Ng DC; Whatt Goh AS
    J Nucl Med; 2012 Apr; 53(4):559-66. PubMed ID: 22343503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study.
    Lau WY; Leung WT; Ho S; Leung NW; Chan M; Lin J; Metreweli C; Johnson P; Li AK
    Br J Cancer; 1994 Nov; 70(5):994-9. PubMed ID: 7947110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nuclear medicine techniques for selective internal radiotherapy of liver cancer].
    Staanum PF; Arveschoug AK; Kramer SM; Nielsen JE; Nielsen DT; Ott P; Grønbæk H; Villadsen GE
    Ugeskr Laeger; 2017 Jan; 179(1):. PubMed ID: 28074772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.